Delivery Order SPE2DB22D3301-SPE2DB25FX8HN
Award Date
1/13/25
Potential Completion Date
2/4/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,955.43, is for the delivery of BOSULIF 400 MG TABLET 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of July 26, 2024 and uses a firm fixed price pricing structure. This delivery order is part of a larger Indefinite...
This is a $11,815.63 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOSULIF 400 MG TABLET 30S, a pharmaceutical product, with a period of performance through June 9, 2025. The contract is not set-aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,631.26, is for the supply of BOSULIF 400 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of June 3, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,334.07, is for the delivery of the medication Bosulif 400 mg tablets. The contract has a firm fixed price pricing type and a completion date of December 16, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued...
The U.S. government awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4566850977 - BOSULIF 400 MG TABLET 30S. The contract has a Firm Fixed Price pricing type, a ceiling value of $45,336.28, and an ultimate completion date of January 29, 2025. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a $5,704.45 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 120 tablets of the prescription drug BOSULIF 100 MG. The contract has an ultimate completion date of June 6, 2025 and is not a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, that...
This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BOSULIF 500 MG TABLET 30S, a pharmaceutical product, with a Firm Fixed Price ceiling value of $5,650.70 and a performance period ending on June 6, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, with a value of $10,955.43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of BOSULIF 400 MG TABLET 30S, with an ultimate completion date of December 3, 2024. The contract type is Firm Fixed Price. This award is not associated with a set-aside designation, indicating open competition. Additionally, AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,339.18 firm fixed-price delivery order is for BOSULIF 100 MG TABLET 120S, with an ultimate completion date of October 4, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The order is for the supply of Bosulif 400 mg tablets, a specialty medication, at a firm fixed price of $21,910.86. The award is not associated with a set-aside program and has an ultimate completion date of September 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...